222 related articles for article (PubMed ID: 20498303)
1. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.
Müller-Tidow C; Klein HU; Hascher A; Isken F; Tickenbrock L; Thoennissen N; Agrawal-Singh S; Tschanter P; Disselhoff C; Wang Y; Becker A; Thiede C; Ehninger G; zur Stadt U; Koschmieder S; Seidl M; Müller FU; Schmitz W; Schlenke P; McClelland M; Berdel WE; Dugas M; Serve H;
Blood; 2010 Nov; 116(18):3564-71. PubMed ID: 20498303
[TBL] [Abstract][Full Text] [Related]
2. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
[TBL] [Abstract][Full Text] [Related]
3. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
Paul TA; Bies J; Small D; Wolff L
Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
[TBL] [Abstract][Full Text] [Related]
4. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
Wiencke JK; Zheng S; Morrison Z; Yeh RF
Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
[TBL] [Abstract][Full Text] [Related]
5. Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.
Tickenbrock L; Klein HU; Trento C; Hascher A; Göllner S; Bäumer N; Kuss R; Agrawal S; Bug G; Serve H; Thiede C; Ehninger G; Stadt UZ; McClelland M; Wang Y; Becker A; Koschmieder S; Berdel WE; Dugas M; Müller-Tidow C;
Leuk Res; 2011 May; 35(5):620-5. PubMed ID: 21176959
[TBL] [Abstract][Full Text] [Related]
6. Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.
Nishioka C; Ikezoe T; Yang J; Yokoyama A
PLoS One; 2015; 10(5):e0125017. PubMed ID: 25955299
[TBL] [Abstract][Full Text] [Related]
7. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of the network of histone H3 lysine 9 trimethylation in acute myeloid leukaemia.
Dong A; Yang W; Huang H; Zhou X; He Z; Yao R; Guo W
Oncol Rep; 2020 Aug; 44(2):543-554. PubMed ID: 32468066
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
10. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
[TBL] [Abstract][Full Text] [Related]
11. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
12. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN
Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619
[TBL] [Abstract][Full Text] [Related]
13. MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.
Sauer T; Arteaga MF; Isken F; Rohde C; Hebestreit K; Mikesch JH; Stelljes M; Cui C; Zhou F; Göllner S; Bäumer N; Köhler G; Krug U; Thiede C; Ehninger G; Edemir B; Schlenke P; Berdel WE; Dugas M; Müller-Tidow C
Exp Hematol; 2015 Sep; 43(9):794-802.e4. PubMed ID: 26072331
[TBL] [Abstract][Full Text] [Related]
14. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
[TBL] [Abstract][Full Text] [Related]
15. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
16. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
17. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
18. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
19. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
20. Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association.
Gebhard C; Glatz D; Schwarzfischer L; Wimmer J; Stasik S; Nuetzel M; Heudobler D; Andreesen R; Ehninger G; Thiede C; Rehli M
Leukemia; 2019 Jan; 33(1):26-36. PubMed ID: 29925905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]